Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zyentia (AggreSolve Technology Platform)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A silico protein analysis platform. The silico protein analysis platform is used to screen proteins to predict aggregation problems, to predict sequence changes likely to reduce aggregation and to design aggregation inhibitors and stabilizers.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Cambridge
  • England

Zyentia (AggreSolve Technology Platform) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Zyentia (AggreSolve Technology Platform)‘s full profile, request access.

Request full access to PitchBook

Zyentia (AggreSolve Technology Platform) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Zyentia (AggreSolve Technology Platform)‘s full profile, request access.

Request full access to PitchBook

Zyentia (AggreSolve Technology Platform) Executive Team (1)

Name Title Board
Seat
Contact
Info
Jesús Zurdo Founder